Acadian Asset Management’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-51,861
Closed -$660K 1809
2022
Q4
$660K Sell
51,861
-71,244
-58% -$641K ﹤0.01% 962
2022
Q3
$712K Buy
123,105
+17,681
+17% +$77.7K ﹤0.01% 894
2022
Q2
$340K Buy
105,424
+96,168
+1,039% +$290K ﹤0.01% 1081
2022
Q1
$34K Buy
+9,256
New +$59.6K ﹤0.01% 1509

Other funds holding ETNB

Acadian Asset Management's ETNB Position: Q1 2023 in Review

Acadian Asset Management sold out of 89bio (ETNB) in Q1 2023, closing a stake of 51,861 shares — an estimated $660K sold.

Acadian Asset Management first reported a position in ETNB in Q1 2022 and held it in 4 quarters. The position peaked at $712K in Q3 2022. 145 funds tracked by Wall St. Rank hold ETNB as of Q1 2023.

  • Acadian Asset Management reported no remaining 89bio position as of Q1 2023 after selling out during the quarter.
  • Acadian Asset Management sold 51,861 89bio shares in Q1 2023, an estimated $660K.
  • Acadian Asset Management first reported a position in 89bio in Q1 2022 and held it in 4 quarters.
  • Acadian Asset Management's 89bio position peaked at $712K in Q3 2022.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q1 2023.

Based on Acadian Asset Management's 13F filing for Q1 2023, filed 11 May 2023.